We wish to add an additional suggestion to the "AASLD Practice Guidelines: Primary Biliary Cirrhosis" that was published last month in HEPATOLOGY 1 and of which we were coauthors. Approximately 40% of patients with primary biliary cirrhosis (PBC) respond incompletely to treatment with ursodiol. Bec
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
โ Scribed by Laura M. Kulik; Brian I. Carr; Mary F. Mulcahy; Robert J. Lewandowski; Bassel Atassi; Robert K. Ryu; Kent T. Sato; Al Benson III; Albert A. Nemcek Jr.; Vanessa L. Gates; Michael Abecassis; Reed A. Omary; Riad Salem
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 229 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background The role of radiofrequency ablation (RFA) for perivascular (up to 5 mm from the major intrahepatic portal vein or hepatic vein branches) hepatocellular carcinoma (HCC) is unclear because of possible incomplete tumour ablation and potential vascular damage. This study aime
## Background: The prognosis of patients with hepatocellular carcinoma (hcc) with portal vein tumor thrombosis (pvtt) is extremely poor. the aim of this study was to elucidate the efficacy of hepatic arterial infusion chemotherapy (haic) for patients with advanced hccs. ## Methods: Forty-eight hc